Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ALUR NASDAQ:BDMD NASDAQ:ICU NASDAQ:OSRH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALURAllurion Technologies$3.12+5.1%$2.71$2.15▼$22.63$23.42M-0.47796,344 shs182,516 shsBDMDBaird Medical Investment$3.12-1.6%$4.60$1.05▼$12.50$20.54M-0.94259,730 shs56,376 shsICUSeaStar Medical$0.71+6.7%$0.92$0.31▼$9.56$7.95M-1.091.78 million shs1.51 million shsOSRHOSR$1.06+6.0%$1.30$1.00▼$13.40$20.43M1.56212,668 shs297,234 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALURAllurion Technologies0.00%+9.86%+27.87%+32.48%-86.75%BDMDBaird Medical Investment0.00%-7.69%-51.63%-44.19%+311,999,900.00%ICUSeaStar Medical0.00%+19.96%-27.58%-43.22%-90.87%OSRHOSR0.00%-10.17%-34.57%-20.30%+105,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALURAllurion Technologies2.9851 of 5 stars3.55.00.00.01.11.70.6BDMDBaird Medical InvestmentN/AN/AN/AN/AN/AN/AN/AN/AICUSeaStar Medical0.4209 of 5 stars0.02.00.00.02.31.70.0OSRHOSRN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALURAllurion Technologies 3.00Buy$22.83631.84% UpsideBDMDBaird Medical Investment 0.00N/AN/AN/AICUSeaStar Medical 0.00N/AN/AN/AOSRHOSR 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALURAllurion Technologies$28.30M0.82N/AN/A($30.08) per share-0.10BDMDBaird Medical InvestmentN/AN/AN/AN/AN/AN/AICUSeaStar Medical$140K56.78N/AN/A($0.34) per share-2.09OSRHOSRN/AN/AN/AN/A($3.87) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALURAllurion Technologies-$26.15M-$12.50N/AN/AN/A-86.05%N/A-41.49%8/12/2025 (Estimated)BDMDBaird Medical InvestmentN/AN/A0.00∞N/AN/AN/AN/AN/AICUSeaStar Medical-$24.83M-$3.47N/A∞N/AN/AN/A-313.28%8/12/2025 (Estimated)OSRHOSR-$2.41MN/A0.00∞N/AN/A-36.89%-19.14%N/ALatest ICU, OSRH, BDMD, and ALUR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025ALURAllurion Technologies-$0.65N/AN/AN/A$6.20 millionN/A5/20/2025Q1 2025OSRHOSRN/A-$1.04N/A-$1.04N/A$0.76 million5/14/2025Q1 2025ALURAllurion Technologies-$1.53$0.43+$1.96$0.20$5.50 million$5.58 million5/14/2025Q1 2025ICUSeaStar Medical-$0.52-$0.44+$0.08-$0.44$0.15 million$0.29 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALURAllurion TechnologiesN/AN/AN/AN/AN/ABDMDBaird Medical InvestmentN/AN/AN/AN/AN/AICUSeaStar MedicalN/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALURAllurion TechnologiesN/A2.091.88BDMDBaird Medical InvestmentN/AN/AN/AICUSeaStar MedicalN/A0.960.96OSRHOSRN/A0.250.20Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALURAllurion Technologies21.39%BDMDBaird Medical Investment19.78%ICUSeaStar Medical1.69%OSRHOSR55.30%Insider OwnershipCompanyInsider OwnershipALURAllurion Technologies22.40%BDMDBaird Medical Investment78.90%ICUSeaStar Medical1.30%OSRHOSR33.67%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALURAllurion Technologies5017.46 million5.79 millionOptionableBDMDBaird Medical InvestmentN/A6.58 million1.39 millionN/AICUSeaStar Medical211.20 million11.06 millionNot OptionableOSRHOSRN/A19.28 million12.79 millionN/AICU, OSRH, BDMD, and ALUR HeadlinesRecent News About These CompaniesOSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR CompanyJuly 15, 2025 | prnewswire.comOSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D ...July 11, 2025 | taiwannews.com.twTOSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG | MorningstarJuly 9, 2025 | morningstar.comMOSR Holdings plans $50 million security token offering in 2025July 9, 2025 | uk.investing.comOSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AGJuly 9, 2025 | prnewswire.comOSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AGJuly 8, 2025 | tmcnet.comOSR Holdings, Inc. (OSRH)June 26, 2025 | uk.finance.yahoo.comOSRH OSR Holdings, Inc.June 4, 2025 | seekingalpha.comOSRH stock touches 52-week low at $1.07 amid market challengesMay 23, 2025 | investing.comOSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH TokenMay 22, 2025 | prnewswire.comDarnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative BiologicsMay 2, 2025 | prnewswire.comDarnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment TechnologyApril 9, 2025 | prnewswire.comOSR Holdings enters $80 mln stock purchase agreement with White Lion GBM Innovation FundApril 3, 2025 | msn.comOSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma TherapiesApril 3, 2025 | prnewswire.comDriving the Future of Healthcare HIT, OSRH, THTX, LPTX, CSDX, Innovations in Health Insurance, Virtual Care, Oncology, and Chronic Disease TreatmentMarch 28, 2025 | insurancenewsnet.comIOSR Holdings Inc.: Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in GlioblastomaMarch 26, 2025 | finanznachrichten.deOSR Holdings Inc.: OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific OfficerMarch 26, 2025 | finanznachrichten.deOSR Holdings Inc OSRHMarch 26, 2025 | morningstar.comMVaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in GlioblastomaMarch 26, 2025 | prnewswire.comOSR Holdings Appoints Dr. Constance Höfer as Chief Scientific OfficerMarch 25, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeICU, OSRH, BDMD, and ALUR Company DescriptionsAllurion Technologies NYSE:ALUR$3.12 +0.15 (+5.05%) Closing price 07/18/2025 03:59 PM EasternExtended Trading$3.07 -0.05 (-1.47%) As of 07/18/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.Baird Medical Investment NASDAQ:BDMD$3.12 -0.05 (-1.58%) As of 07/18/2025 04:00 PM EasternBaird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.SeaStar Medical NASDAQ:ICU$0.71 +0.04 (+6.74%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$0.68 -0.03 (-4.18%) As of 07/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.OSR NASDAQ:OSRH$1.06 +0.06 (+6.00%) As of 07/18/2025 03:41 PM EasternOSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
